These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17214577)

  • 1. Blockade of chemokine-mediated tissue injury in lupus nephritis.
    Vielhauer V; Anders HJ
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):313-21. PubMed ID: 17214577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V; Anders HJ; Schlöndorff D
    Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in lupus nephritis.
    Kulkarni O; Anders HJ
    Front Biosci; 2008 May; 13():3312-20. PubMed ID: 18508434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine blockade for lupus model mice.
    Hasegawa H
    Front Biosci; 2008 Jan; 13():2900-8. PubMed ID: 17981762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and Chemokine Receptors in the Development of Lupus Nephritis.
    Liao X; Pirapakaran T; Luo XM
    Mediators Inflamm; 2016; 2016():6012715. PubMed ID: 27403037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
    Devarapu SK; Kumar Vr S; Rupanagudi KV; Kulkarni OP; Eulberg D; Klussmann S; Anders HJ
    Clin Immunol; 2016 Aug; 169():139-147. PubMed ID: 27392463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.
    Avihingsanon Y; Phumesin P; Benjachat T; Akkasilpa S; Kittikowit V; Praditpornsilpa K; Wongpiyabavorn J; Eiam-Ong S; Hemachudha T; Tungsanga K; Hirankarn N
    Kidney Int; 2006 Feb; 69(4):747-53. PubMed ID: 16518330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    Anders HJ; Belemezova E; Eis V; Segerer S; Vielhauer V; Perez de Lema G; Kretzler M; Cohen CD; Frink M; Horuk R; Hudkins KL; Alpers CE; Mampaso F; Schlöndorff D
    J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal-infiltrating CD11c
    Liao X; Ren J; Reihl A; Pirapakaran T; Sreekumar B; Cecere TE; Reilly CM; Luo XM
    Clin Exp Immunol; 2017 Nov; 190(2):187-200. PubMed ID: 28722110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine blockade as a therapy for renal disease.
    Rovin BH
    Curr Opin Nephrol Hypertens; 2000 May; 9(3):225-32. PubMed ID: 10847322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis.
    Kanapathippillai P; Hedberg A; Fenton CG; Fenton KA
    Cytokine; 2013 May; 62(2):244-52. PubMed ID: 23561928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective role for CCR5 in murine lupus nephritis.
    Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CCL2/MCP1: a novel target in systemic lupus erythematosus and lupus nephritis].
    Kulkarni O; Anders HJ
    Z Rheumatol; 2008 May; 67(3):220-4. PubMed ID: 18398619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of chemokine like factor-1 in nephridial tissue of lupus nephritis].
    Ji Y; Zhang H; Yuan H; Yang GP; Zhang K; Xie LH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):490-3. PubMed ID: 17611331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questions about chemokine and chemokine receptor antagonism in renal inflammation.
    Anders HJ; Sayyed SA; Vielhauer V
    Nephron Exp Nephrol; 2010; 114(2):e33-8. PubMed ID: 19887844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines as therapeutic targets in renal inflammation.
    Rovin BH
    Am J Kidney Dis; 1999 Oct; 34(4):761-4; discussion 765-7. PubMed ID: 10516362
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelial chemokines in autoimmune disease.
    Christopherson KW; Hromas RA
    Curr Pharm Des; 2004; 10(2):145-54. PubMed ID: 14754394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines: novel targets for breast cancer metastasis.
    Ali S; Lazennec G
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):401-20. PubMed ID: 17717637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine chemokines: biomarkers of human lupus nephritis?
    Ferri GM; Gigante A; Ferri F; Amoroso D; Zardi E; Papa A; De Galasso L; Amoroso A
    Eur Rev Med Pharmacol Sci; 2007; 11(3):171-8. PubMed ID: 17970233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the chemokine system for multiple sclerosis treatment.
    Glabinsk AR; Ransohoff RM
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1712-9. PubMed ID: 11892933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.